The NextGen VC Podcast

The NextGen VC Podcast

LaunchBio
Country USA
Language EN
Episodes 24
Latest 30.10.2026

The NextGen VC Podcast is aimed at venture capitalists who want to sharpen their skills and stay current in life sciences investing. It explores the opportunities, challenges, and breakthroughs shaping the sector today. The show is curated by Wilson Sonsini and LaunchBio and hosted by Michael Hostetler and Jen Fang. It also points listeners to related in-person NextGen VC events and life sciences community resources from LaunchBio.

Episodes

  • The Scientist Who Said Yes to Everything — and Ended Up in VC
    The Scientist Who Said Yes to Everything — and Ended Up in VC 30.10.2026 49m
    Nandita Shangari didn’t plan to end up in venture capital. She was a toxicologist at Novartis, and said yes to one unplanned opportunity after another, until she’d worked on Kymriah (the first FDA-approved CAR T therapy), ran the Novartis Venture Fund, and ultimately landed at RA Capital Management, where she’s now Managing Director.In this episode, Jen and Mike trace that path with her and get into what she’s learned along the way about the “performance equity” that opens doors, how RA’s incubator builds companies fast, and the real story behind Capstan Therapeutics’ pivot from oncology to au...
  • Why the Future of Biotech Starts With the Brain
    Why the Future of Biotech Starts With the Brain 07.07.2026 49m
    What does neuroscience have to do with venture capital? Quite a bit, according to Jason Pitts.In this episode of the NextGen VC podcast, Mike Hostetler and Jen Fang sit down with Jason, Principal at General Atlantic, to talk about the winding path that took him from studying the brain at Cornell to evaluating some of the most promising companies in biotech.Jason shares how a series of unexpected opportunities led him from the lab at Regeneron to McKinsey and ultimately into venture investing. Along the way, he reflects on the mentors, relationships, and career pivots that shaped his journey.Th...
  • The $2.25B Exit That Changed Lumira's Investment Strategy
    The $2.25B Exit That Changed Lumira's Investment Strategy 08.06.2026 47m
    Jen and Mike sit down with Dr. Suman Rao, Principal at Lumira Ventures, to discuss her path from academic science to healthcare venture capital and why she believes the best investors lead with mission before money.Rao shares Lumira’s approach to investing beyond traditional biotech hubs, the firm’s sidecar fund model with partners like Merck and the Terry Fox Foundation, and the story behind Histosonics, a Midwest medtech company that grew into a $2.25B exit and helped shape Lumira’s next investment thesis. She also offers candid advice for aspiring VCs: don’t follow the prescribed path. Buil...
  • Aimee Raleigh (Atlas Venture): Building Biotech Companies from Day One
    Aimee Raleigh (Atlas Venture): Building Biotech Companies from Day One 06.05.2026 53m
    What does it actually take to turn an idea into a biotech company?Aimee Raleigh, PhD, Principal at Atlas Venture, joins Mike and Jen as she walks through how companies get built before they’re even companies. From evaluating early science to forming a real point of view, Aimee shares how investors build conviction at the earliest stages.We get into the pace of early-stage venture, how to juggle multiple opportunities, make decisions with imperfect data, figure out what’s worth leaning into, and more. Aimee discusses her path into venture and what she’s learned along the way in an industry that...
  • From Scalpel to Term Sheet: Rich Gaster on Building Conviction, Backing Winners, and Fighting for Claire
    From Scalpel to Term Sheet: Rich Gaster on Building Conviction, Backing Winners, and Fighting for Claire 08.04.2026 51m
    What does it take to go from performing reconstructive plastic surgeries at Harvard to becoming a managing partner at one of biotech's most focused venture firms? Rich Gaster, Managing Partner at venBio Partners, joins Mike and Jen to trace a career path that runs through Stanford MD-PhD training, two grad school startups, the company-building engine at Third Rock Ventures, and the founding team of Pliant Therapeutics — before landing at venBio, where he helped engineer three back-to-back acquisitions in a single quarter.Rich breaks down what makes venBio's small-team, high-conviction model so...
  • Anna French on Building Qiming in the States and the Global Future of Biotech
    Anna French on Building Qiming in the States and the Global Future of Biotech 27.03.2026 55m
    Dr. Anna French, Managing Partner at Qiming Venture Partners USA, joins the NextGen VC Podcast to trace her nonlinear path from an Oxford DPhil and BCG boardrooms to becoming employee #1 at one of biotech's most globally connected venture firms. Anna shares what it's really like to build a fund from the ground up, why she championed Umoja Biopharma's bold bet on in vivo CAR-T and in-house manufacturing, and how a global perspective — forged in UK labs, Korean hospitals, and Parisian roundtables — shapes the way she looks for innovation. She shares candidly about LP fundraising, the US-China bi...
  • Risk, Rigor, and Reality: Suan Tuang on Investing Across Private and Public Biotech
    Risk, Rigor, and Reality: Suan Tuang on Investing Across Private and Public Biotech 04.02.2026 46m
    Suan Tuang didn’t take a traditional path into biotech investing, and this journey shapes how he evaluates risk today. Now at TCG Crossover, and with prior experience at Foresite and Eventide, Suan brings a clinician-scientist lens to investing across private and public markets. In this episode, Suan shares how his immigrant journey and academic challenges at MIT and Harvard have shaped his unique approach to risk and resilience. Learn how he leverages clinical data over hype, balances scientific rigor with market realities, and more. Suan also offers practical advice for aspiring investors an...
  • The Science of Company Building: A Conversation with Third Rock’s Noreen Rizvi
    The Science of Company Building: A Conversation with Third Rock’s Noreen Rizvi 15.01.2026 39m
    What does it take to turn breakthrough science into a breakthrough company? In this episode of the NextGen VC Podcast, we sit down with Noreen Rizvi, Principal at Third Rock Ventures, whose journey from chemical engineering to venture creation offers a rare look inside the art and science of biotech investing. Noreen discusses how she bridges science and strategy, what she’s learned from building companies like Trace Neuro and Faze Medicine, and why Third Rock spends years incubating ideas before launch. She also shares how mentorship, collaboration, and a “take the call” mindset have shaped h...
  • Breaking Barriers: Dr. Tia Lyles-Williams on Biotech Innovation and Mentorship
    Breaking Barriers: Dr. Tia Lyles-Williams on Biotech Innovation and Mentorship 09.09.2025 42m
    Join us on the NextGenVC Podcast as we dive into the inspiring journey of Dr. Tia Lyles-Williams, a trailblazer in the biotech industry. Discover how mentorship shaped her path, the challenges she overcame, and her vision for inclusive biotech innovation through her accelerator, HiveBio. Dr. Tia shares insights on building a community-driven biotech ecosystem and the importance of perseverance in the face of obstacles. Tune in for an engaging conversation that highlights the dynamic world of venture capital and biotech in Philadelphia.
  • Unlocking Biotech's Full Potential: A Conversation with Excedr's Jon Chee
    Unlocking Biotech's Full Potential: A Conversation with Excedr's Jon Chee 09.07.2025 37m
    Hosts Mike Hostetler and Jen Fang are joined by Jon Chee, CEO of Excedr and host of The Biotech Startups Podcast. Jon shares insights from his work with early-stage life science companies, trends he's observing in biotech, and what he’s learned from interviewing founders and industry leaders on his own podcast. He also reflects on the importance of company culture, capital structure, and resilience in building successful biotech ventures. Tune in to hear how Jon is helping founders navigate startup challenges, scale smarter, and stay focused on science.
  • Exploring Venture Capital Investing in China with OrbiMed's Ran Geng
    Exploring Venture Capital Investing in China with OrbiMed's Ran Geng 03.06.2025 33m
    In this episode, hosts Jen Fang and Mike Hostetler welcome guest Ran Geng, a Principal on the Private Equity Team at OrbiMed. The discussion covers the unique opportunities and challenges in the Chinese market, including government policies, the rise of tech startups, and more. They also explore the influence of China's rapid technological advancements, current investment trends, and strategies investors can adopt to succeed in this quickly evolving landscape.
  • The Intersection of Venture Capital and Biotech Innovation: A Conversation with Chris Garabedian
    The Intersection of Venture Capital and Biotech Innovation: A Conversation with Chris Garabedian 20.05.2025 39m
    In this episode of the NextGenVC podcast, hosts Jen Fang and Mike Hostetler are joined by Chris Garabedian, founder of Xontogeny and biopharma veteran, to discuss the transformative impact of early-stage biotech investment. Chris shares his journey from biotech corporate leadership to venture capital, emphasizing the importance of thoughtful drug development and the value of nurturing early-stage companies. He explains the inception of Xontogeny, its collaboration with Perceptive Advisors, and the unique venture incubation model they follow. Chris also highlights the essential qualities for su...
  • Building Biotech from the Ground Up with Dr. Josep Bassaganya-Riera
    Building Biotech from the Ground Up with Dr. Josep Bassaganya-Riera 22.04.2025 32m
    On this episode of the NextGen VC Podcast, we’re joined by Dr. Josep Bassaganya-Riera, the president and CEO of NImmune Biopharma and founder of The NIMML Institute, a nonprofit research organization. A scientist turned entrepreneur, Josep shares his journey from academia to launching multiple biotech ventures, including Lando Biopharma (acquired by AbbVie). He reflects on the pivotal moments that led him to leave the university world and build companies at the intersection of science and innovation. We dive into the early stages of company formation, his experiences working with investors lik...
  • Unveiling the Future of Biotech VC with Felix Breyer: Insights and Innovations
    Unveiling the Future of Biotech VC with Felix Breyer: Insights and Innovations 18.03.2025 49m
    In this episode of the Next Gen VC podcast, hosts Mike Hostetler and Jen Fang sit down with Felix Breyer from J.P. Morgan Life Sciences Private Capital. Felix, with a background as a molecular and cellular biologist, dives deep into the critical role of private capital in life sciences and biotech. He shares his journey from academia to venture capital, emphasizes the importance of mentorship, and provides an insider's perspective on the evolving landscape of biotech investing. Tune in to explore key trends, challenges, and opportunities in the biotech sector, and gain valuable insights for as...
  • Enrique Lin Shiao: Navigating Science, Venture Philanthropy, and Genetic Medicine
    Enrique Lin Shiao: Navigating Science, Venture Philanthropy, and Genetic Medicine 18.02.2025 46m
    In this episode of the NextGenVC podcast, Mike Hostetler and Jen Fang sit down with Enrique Lin Shiao, a venture investor and fellow podcaster, to discuss his fascinating journey from earning a PhD at the University of Pennsylvania to becoming a key player in venture philanthropy, especially in the realm of cystic fibrosis research and treatment. Enrique shares his experiences with his podcast ‘Caminos en Ciencia,’ his insights into the development and challenges of genetic medicine, and the impactful work being done at the Cystic Fibrosis Foundation. Tune in to explore how his diverse backgro...
  • Exploring the Intersection of Biotech and Corporate VC with Danjuma Quarless
    Exploring the Intersection of Biotech and Corporate VC with Danjuma Quarless 10.12.2024 36m
    In this episode of the NextGen VC podcast, hosts Mike Hostetler and Jen sit down with Danjuma Quarless from AbbVie Ventures to delve into the world of corporate venture capital. Danjuma shares insights on how corporate VCs like AbbVie differ from traditional VCs, particularly in the biotech and pharmaceutical industries. Listeners will learn about the strategic focus of AbbVie Ventures, the importance of scientific and competitive differentiation in securing investment, and the fluid communication within AbbVie's ecosystem. Danjuma also shares his personal journey from a research scientist to...
  • A Deep Dive into MedTech VC, Part 2: Jeff Chu
    A Deep Dive into MedTech VC, Part 2: Jeff Chu 16.10.2024 50m
    The NextGen VC Podcast's next episode highlights Jeff Chu, founder and managing partner of Features Capital, an early-stage medtech venture capital firm. Hosted by Mike Hostetler and Jen Fang, partners at Wilson Sonsini, the discussion explores Jeff's journey from owning a consulting firm to co-founding a venture fund, the unique approach that Features Capital takes towards investing in medtech startups, and the importance of diversity and first-generation wealth creators in the venture capital space. Jeff also shares the personal philosophies and strategies that have shaped his career and now...
  • A Deep Dive into MedTech VC, Part 1: Jenny Barba
    A Deep Dive into MedTech VC, Part 1: Jenny Barba 02.10.2024 48m
    This episode features an in-depth conversation with Jenny Barba, founder and managing partner of Features Capital, an early-stage medtech venture capital firm. Hosts Mike Hostetler and Jen Fang explore Jenny's journey from neuroscience and finance to founding her own VC firm, her passion for supporting diverse and first-time founders in MedTech, and the unique challenges and opportunities in venture capital investment. Listen to gain a behind-the-scenes look at building a portfolio. Jenny also shares personal anecdotes, including the touching story behind the name 'Features Capital,' driven by...
  • Data-Driven Decisions: Unpacking VC Compensation with Jody & Morgan Thelander
    Data-Driven Decisions: Unpacking VC Compensation with Jody & Morgan Thelander 28.08.2024 39m
    In this episode of the NextGen VC Podcast, we explore the intricacies of venture capital compensation with Jody and Morgan Thelander of Thelander Consulting. With a deep background in executive compensation and a unique understanding of the biotech industry, Jody shares how Thelander Consulting’s real-time compensation survey has become an essential resource for over 5,000 investment firms. Jody and Morgan discuss crucial aspects of VC compensation, including base pay, bonuses, and carried interest. They share insights for both established VCs and those new to the industry. Whether you’re stru...
  • Journey to Venture Capital: Insights with Jeni Lee
    Journey to Venture Capital: Insights with Jeni Lee 09.07.2024 44m
    In this episode of the NextGenVC podcast, hosts Mike Hostetler and Jen Fang engage in an in-depth discussion with Jeni Lee, a partner at Pivotal bioVenture Partners, which invests in transformative therapeutic-focused healthcare companies. They cover a range of topics, from the announcement of Pivotal's second fund to specific investment strategies and the unique aspects of investing in life sciences. Jeni also shares insights into her PhD journey, her strategy in transitioning into the investment world, the importance of embracing risk and what has shaped her career trajectory thus far. The c...

Popular in

The podcast also appears in the podcast charts of these countries.